In this feature story, Northwestern scientists share their work at the forefront of HIV research, pioneering new strategies to investigate, treat, and work towards a cure for the disease.
Menu
Browsing: HIV/AIDS
New advances in CRISPR gene-editing technology may lead to longer-lasting treatments and new therapeutic strategies for HIV/AIDS.
Frank Palella, MD, is working towards increasing the lifespan and “healthspan” of people living with HIV through research, education and patient care as director of the new Potocsnak Center for Aging and HIV.
Associate vice president of research Richard D’Aquila, MD, shares his perspective on the news of a possible third person cured of HIV, and the progress of HIV research in the future.
Marijuana use among pregnant and postpartum individuals living with HIV increased from 2007 to 2019, according to a Northwestern Medicine study.
A novel combination treatment may increase the ability of monoclonal antibodies to control viral infection in patients diagnosed with HIV, according to a Northwestern Medicine study.
Three Feinberg students have received Harvard-BU-Northwestern-University of New Mexico Fogarty Global Health Fellowships, supporting work in Botswana, South Africa and Tanzania.
Northwestern Medicine investigators have discovered that a specialized protein associated with the microtubules of a cell helps facilitate and regulate early stages of HIV infection.
An emerging cancer treatment also helps prevent cells from turning into viral factories by interfering with HIV infection processes inside the cell, according to a recent study.
A recent campus talk explored how clinical trials of HIV/AIDS drugs in developing countries in the 90s sparked a wealth of discussions about ethics in scientific investigation and barriers to healthcare access.